Efficacy and Safety of Exenatide in Japanese Patients with Type 2 Diabetes Who are Treated with Oral Antidiabetic(s)

Study identifier:H8O-JE-GWBB

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Efficacy and Safety of LY2148568 in Japanese Patients with Type 2 Diabetes Who are Treated with Oral Antidiabetic(s) but not well Controlled

Medical condition

Type 2 Diabetes

Phase

Phase 3

Healthy volunteers

No

Study drug

exenatide, placebo

Sex

All

Actual Enrollment

181

Study type

Interventional

Age

20 Years - 75 Years

Date

Study Start Date: 01 Jan 2008
Primary Completion Date: 01 Nov 2008
Study Completion Date: 01 Nov 2008

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Mar 2015 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

Eli Lilly and Company

Inclusion and exclusion criteria